InspireMD Financial Statements From 2010 to 2026

NSPR Stock  USD 1.75  0.05  2.94%   
InspireMD's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing InspireMD's valuation are provided below:
Gross Profit
1.9 M
Market Capitalization
74.1 M
Enterprise Value Revenue
1.815
Revenue
7.8 M
Earnings Share
(0.82)
There are over one hundred nineteen available fundamental trends for InspireMD, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to confirm InspireMD's regular fundamental performance against the performance between 2010 and 2026 to make sure the trends are evolving in the right direction. As of 02/18/2026, Market Cap is likely to drop to about 24.2 M. In addition to that, Enterprise Value is likely to drop to about 12.4 M

InspireMD Total Revenue

4.64 Million

Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 18.5 M, as well as many indicators such as Price To Sales Ratio of 17.19, Dividend Yield of 0.0 or PTB Ratio of 3.34. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Build AI portfolio with InspireMD Stock
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

InspireMD Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets56.5 M53.8 M24.2 M
Slightly volatile
Other Current Liabilities7.1 M6.8 M3.5 M
Slightly volatile
Total Current Liabilities4.4 M8.8 MM
Slightly volatile
Cash22.8 M21.8 M11 M
Slightly volatile
Cash And Short Term Investments41.8 M39.8 M17.3 M
Slightly volatile
Common Stock Shares Outstanding50.6 M48.2 M10.7 M
Slightly volatile
Liabilities And Stockholders Equity56.5 M53.8 M23.2 M
Slightly volatile
Other Stockholder Equity349.7 M333 M168.3 M
Slightly volatile
Total Liabilities7.6 M12.3 M8.5 M
Slightly volatile
Total Current Assets48.9 M46.6 M21.5 M
Slightly volatile
Short and Long Term Debt TotalM2.1 M3.4 M
Slightly volatile
Non Current Assets Total7.6 M7.2 M2.8 M
Slightly volatile
Non Currrent Assets Other748.4 K1.4 M951.8 K
Very volatile
Net Receivables1.4 M2.6 M1.4 M
Pretty Stable
Non Current Liabilities Total2.5 M2.7 M3.1 M
Slightly volatile
Inventory1.2 M2.3 M1.5 M
Pretty Stable
Property Plant And Equipment Gross8.5 M8.1 M2.3 M
Slightly volatile
Other Liabilities738.6 K1.1 M741.3 K
Slightly volatile
Property Plant And Equipment Net5.7 M5.4 M1.8 M
Slightly volatile
Current Deferred Revenue17.1 K18 K77.1 K
Slightly volatile
Accounts Payable797.1 K1.4 M771.1 K
Slightly volatile
Other Current Assets1.3 M1.2 M563.2 K
Slightly volatile
Property Plant EquipmentM2.8 M1.2 M
Slightly volatile
Long Term Debt Total939.6 K989.1 K2.3 M
Slightly volatile
Capital Surpluse157.7 M207.4 M147.5 M
Slightly volatile
Non Current Liabilities Other2.3 M2.2 M1.3 M
Slightly volatile
Deferred Long Term Asset Charges68 K76.5 K83.5 K
Slightly volatile
Warrants219.2 K246.6 K269.2 K
Slightly volatile
Net Invested Capital21.4 M41.5 M14 M
Slightly volatile
Net Working Capital20.3 M37.8 M13.2 M
Slightly volatile
Capital Lease Obligations1.7 M2.7 M1.3 M
Slightly volatile

InspireMD Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization194.1 K322 K191.1 K
Slightly volatile
Selling General Administrative18.5 M17.6 M10.4 M
Very volatile
Total Revenue4.6 M8.1 M4.5 M
Slightly volatile
Other Operating Expenses48.9 M46.6 M21.9 M
Slightly volatile
Total Operating Expenses42.3 M40.3 M18.7 M
Slightly volatile
Research Development16.5 M15.7 M6.1 M
Slightly volatile
Cost Of Revenue3.3 M6.3 M3.2 M
Slightly volatile
Selling And Marketing Expenses3.5 MM3.4 M
Slightly volatile
Non Recurring785.6 K883.8 K964.7 K
Slightly volatile
Interest Income912.1 K1.8 M815.2 K
Very volatile
Reconciled Depreciation206.2 K322 K192.6 K
Slightly volatile

InspireMD Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow7.7 M11.1 M8.1 M
Pretty Stable
End Period Cash Flow22.8 M21.8 M10.2 M
Slightly volatile
Depreciation200.4 K322 K191.5 K
Slightly volatile
Stock Based Compensation9.6 M9.1 M4.9 M
Very volatile
Issuance Of Capital Stock1.7 M1.8 M16.8 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.1918.09427
Slightly volatile
Days Sales Outstanding129135122
Pretty Stable
Stock Based Compensation To Revenue0.881.660.858
Pretty Stable
Capex To Depreciation4.734.511.8566
Slightly volatile
Inventory Turnover1.891.932.249
Pretty Stable
Days Of Inventory On Hand198196186
Slightly volatile
Payables Turnover3.743.954.3829
Pretty Stable
Sales General And Administrative To Revenue1.571.971.8962
Very volatile
Research And Ddevelopement To Revenue0.91.751.1379
Pretty Stable
Capex To Revenue0.190.180.0743
Slightly volatile
Cash Per Share0.90.9578.3 K
Slightly volatile
Days Payables Outstanding10995.65109
Slightly volatile
Income Quality0.580.610.7062
Slightly volatile
Current Ratio2.714.753.5558
Slightly volatile
Receivables Turnover2.592.83.1228
Pretty Stable
Capex Per Share0.03650.03854.1 K
Slightly volatile
Revenue Per Share0.180.19124.1 K
Slightly volatile
Debt To Assets0.05460.05740.231
Slightly volatile
Operating Cycle327331308
Slightly volatile
Days Of Payables Outstanding10995.65109
Slightly volatile
Ebt Per Ebit1.041.142.241
Slightly volatile
Total Debt To Capitalization0.06650.070.3871
Slightly volatile
Quick Ratio2.494.453.2758
Slightly volatile
Net Income Per E B T0.70.90.9189
Pretty Stable
Cash Ratio1.52.221.933
Pretty Stable
Cash Conversion Cycle218235199
Very volatile
Days Of Inventory Outstanding198196186
Slightly volatile
Days Of Sales Outstanding129135122
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.820.961.0067
Slightly volatile
Fixed Asset Turnover1.621.75.1938
Slightly volatile
Debt Ratio0.05460.05740.231
Slightly volatile
Price Sales Ratio17.1918.09427
Slightly volatile
Asset Turnover0.160.1740.9808
Slightly volatile

InspireMD Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap24.2 M25.5 M22.5 M
Pretty Stable

InspireMD Fundamental Market Drivers

Forward Price Earnings11.6959
Cash And Short Term Investments34.6 M

InspireMD Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue18 K17.1 K
Total Revenue8.1 M4.6 M
Cost Of Revenue6.3 M3.3 M
Stock Based Compensation To Revenue 1.66  0.88 
Sales General And Administrative To Revenue 1.97  1.57 
Research And Ddevelopement To Revenue 1.75  0.90 
Capex To Revenue 0.18  0.19 
Revenue Per Share 0.19  0.18 
Ebit Per Revenue(5.50)(5.77)

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving against InspireMD Stock

  0.77SKAN SKAN Group AGPairCorr
  0.74ECOR Electrocore LLCPairCorr
  0.73VREX Varex Imaging CorpPairCorr
  0.68EKSO Ekso Bionics Holdings TrendingPairCorr
  0.66EDAP EDAP TMS SAPairCorr
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.